SRA737

SRA737 · Sierra Oncology LLC - a GSK company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SRA737, covering 2022-03-10 to 2023-06-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects [Phase 1, Phase 2]

See pricing